Svetlana I. Nihtyanova
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis.
Journal: Rheumatology (Oxford, England)
Published: June 14, 2024
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Journal: Rheumatology (Oxford, England)
Published: December 01, 2022
Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 03, 2022
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: April 02, 2021
Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: January 19, 2021
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis.
Journal: The Journal of rheumatology
Published: February 28, 2020
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 17, 2020
High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: January 16, 2020
Pathogenesis of systemic sclerosis associated interstitial lung disease.
Journal: Journal of scleroderma and related disorders
Published: October 31, 2019
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Journal: Clinical rheumatology
Published: September 26, 2019
Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre.
Journal: Journal of scleroderma and related disorders
Published: August 03, 2019
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.
Journal: Annals of the rheumatic diseases
Published: April 04, 2019
Last Updated: 09/26/2026